Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The future of ciltacabtagene autoleucel in multiple myeloma has just begun.

Nature reviews. Clinical oncology·2026
Same author

Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation.

JCO oncology practice·2026
Same author

International Survey and Next-Generation Sequencing-Based Indel Chimerism Detection of Human Leukocyte Antigens Loss in Relapsed Haploidentical and Mismatched Unrelated Donor Transplant Recipients.

Transplantation and cellular therapy·2026
Same author

Reconsidering the role of bone marrow as a graft source in haploidentical allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2026
Same author

Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

Blood cancer discovery·2026
Same author

Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism.

The New England journal of medicine·2026

相关实验视频

Updated: Sep 11, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K

对CMMLML进行全基因移植.

Nico Gagelmann1, Nihar Desai2,3

  • 1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. nico.gagelmann@posteo.de.

Current hematologic malignancy reports
|August 11, 2025
PubMed
概括

全基性造血细胞移植 (allo-HCT) 是慢性髓性单细胞白血病 (CMML) 的关键治疗方法. 个性化移植时间和优化策略显著改善CMML患者的治疗结果和预期寿命.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 干细胞移植 干细胞移植

背景情况:

  • 慢性骨髓单细胞白血病 (CMML) 是一种罕见的血液性恶性瘤.
  • 它搭建了一个桥梁,跨越了骨髓发育性瘤 (MDS) 和骨髓扩散性瘤,主要影响老年人.
  • 全基性造血细胞移植 (allo-HCT) 是唯一的治愈选择,但受患者年龄和并发症的限制.

研究的目的:

  • 审查CMML不断变化的管理.
  • 要突出allo-HCT在CMML治疗中的关键作用.
  • 讨论患者分层和移植优化方面的进展.

主要方法:

  • 关于CMML管理的最新研究和临床数据的审查.
  • 对影响alo-HCT结果的因素的分析.
  • 评估新的治疗策略和预后工具.

主要成果:

  • 个性化移植时间显著改善CMML患者的预期寿命.
  • 优化结果需要管理腹巨,脱皮,供体选择和调节方案.
  • 以三硫为基础的治疗方案和硫基硫治疗方案显示出良好的毒性和复发概况.
  • 移植后的策略,如PTCy和MRD监测,可以完善患者管理.

更多相关视频

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

2.1K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K

相关实验视频

Last Updated: Sep 11, 2025

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.7K
Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice
10:02

Intra-Peritoneal Transplantation for Generating Acute Myeloid Leukemia in Mice

Published on: January 6, 2023

2.1K
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

9.9K
  • 目前正在研究创新疗法,以改善移植前和移植后的结果.

    • 结论:

    • 分子分类和预后工具的进步正在重塑CMML治疗.
    • 个性化方法整合遗传风险,健康状况和疾病特征,增强移植策略.
    • 最终的目标是延长CMML患者的生存时间和改善生活质量.